What You Should Know:
– Ciba Health, a cutting-edge digital health company simplifying healthcare with a personalized, whole person-care approach to prevent and reverse chronic diseases through root-cause treatment, today announced rapid growth and an expansion to its leadership team on the heels of its $10M Series A funding.
– Ciba Health raised an oversubscribed $10M Series A funding round led by DigiTx Partners, with participation from E12 Ventures, 3CC Capital, Plug and Play Ventures and angel investors.
Ciba Health Elevates Leadership Team to Drive Innovation in Whole Person-Care Revolution
Ciba Health, a pioneer in whole person-care disrupting traditional healthcare with a root-cause approach, has announced key appointments to its leadership team. Nwamaka Imasogie, formerly a Principal Software Engineer on the healthcare AI team at Microsoft, joins as Chief Technology Officer, while Roger Chahine has been promoted from Chief Strategy and Operating Officer to President. Imasogie and Chahine bring with them extensive technology and healthcare expertise, fortifying Ciba Health’s position as an industry leader.
The company’s innovative approach combines expert care teams, advanced lab testing, and a root-cause methodology to revolutionize the prevention and treatment of chronic diseases like type 2 diabetes and digestive health issues. With a focus on accelerating product development and scaling operations to meet burgeoning market demand, Ciba Health bridges gaps between primary providers and specialists to deliver personalized, comprehensive care programs. Its onboarding process, including a thorough questionnaire and extensive clinical tests identifying over 300 lab markers, surpasses traditional methods by a significant margin.
Ciba Health’s services extend to both employer-based benefits and individual adults and dependents, currently serving over 97,000 individuals with an impressive provider retention rate of 98%. Since its inception in 2020, the company has experienced remarkable growth, boasting a 100% revenue increase year over year and a 300% surge in platform patients.
Imasogie, previously Chief Technology Officer at an AI medical software company, brings a track record of rapid product development to her new role, where she will drive scalability through algorithmic implementation and streamlined processes. Chahine, with experience as a Founding Partner at Day223 Ventures, will lead business development efforts and international expansion as President of Ciba Health.
Recent initiatives include the launch of a Pediatric Metabolic Program in March, catering to children aged five and older, and strategic partnerships with Instacart Health and Solera Health to enhance nutrition services and expand employer offerings. Ciba Health plans to further revolutionize the digital health sector by fostering high-touch, technology-driven solutions and expanding collaborations with third-party administrators and health plans.
“We are thrilled to have secured this investment from such a respected group of investors,” said Dr. Innocent Clement, CEO of Ciba Health. “Their support validates our vision and commitment to creating a healthcare system with no gaps, so patients and their providers have all the information needed to treat and reverse chronic diseases with a more holistic approach. We will leverage this funding to drive the growth of our platform and make a meaningful impact on the lives of patients worldwide through a root-cause medicinal approach.”
